List of works - Robert T. Chen

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

scientific article published on 01 February 2004

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

scientific article

Guillain-Barré syndrome following influenza vaccination

scientific article

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

scientific article

Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults

scientific article published on April 1, 2003

The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).

scientific article published in December 2002

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

scientific article

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

scientific article published on October 2006

Active surveillance of vaccine safety: a system to detect early signs of adverse events

scientific article published on May 2005

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children

scientific article

Safety of the trivalent inactivated influenza vaccine among children: a population-based study

scientific article

The development of standardized case definitions and guidelines for adverse events following immunization

scientific article published on 12 March 2007

Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases

scientific article (publication date: November 2003)

Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States

scientific article

Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome

scientific article

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases

scientific article published on 27 November 2006

Emerging vaccine informatics

scientific article

The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety

scientific article published in September 2004

Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies

scientific article

Rates of adverse events associated with male circumcision in U.S. medical settings, 2001 to 2010.

scientific article

A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001

scientific article published on 01 August 2004

Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment

scientific article

Childhood vaccinations and risk of asthma

scientific article published in June 2002

The Brighton Collaboration: enhancing comparability of vaccine safety data

scientific article

Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.

scientific article

Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study.

scientific article published on September 2006

Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems

scientific article

Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment

scientific article published on 6 July 2016

Circumcision status and HIV infection among MSM: reanalysis of a Phase III HIV vaccine clinical trial

scientific article

Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15–59 years of age

scientific article published on July 16, 2011

Standardized case definitions of adverse events following immunization (AEFI)

scientific article published on 01 January 2004

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).

scientific article

Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination

scientific article published in July 2003

Adverse event reports following vaccination for Lyme disease: December 1998-July 2000

article

Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines

scientific article published on 21 May 2013

Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program.

scientific article published on 16 March 2005

Myocarditis: the unexpected return of smallpox vaccine adverse events

scientific article published on October 25, 2003

Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997.

scientific article

Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines

scientific article

The Brighton Collaboration-enhancing vaccine safety

scientific article published on 01 May 2004

Template protocol for clinical trials investigating vaccines--focus on safety elements

scientific article

Men Who Have Sex With Men in Kisumu, Kenya: Comfort in Accessing Health Services and Willingness to Participate in HIV Prevention Studies

scientific article published on January 1, 2014

Enhancing vaccine safety capacity globally: A lifecycle perspective

scientific article

An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?

scientific article published on April 2004

Hepatitis B vaccine and risk of multiple sclerosis

scientific article

Wheezing lower respiratory disease and vaccination of full-term infants

scientific article

Compliance With National Immunization Guidelines for Children Younger Than 2 Years, 1996-1999

scientific article published in February 2005

Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial

scientific article published on 31 May 2017

Modeling the impact of RV144-like vaccines on HIV transmission

scientific article

Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

scientific article published on 25 May 2020

List of works by Robert T. Chen

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

Guillain-Barré syndrome following influenza vaccination

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults

The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

Active surveillance of vaccine safety: a system to detect early signs of adverse events

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children

Safety of the trivalent inactivated influenza vaccine among children: a population-based study

The development of standardized case definitions and guidelines for adverse events following immunization

Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases

Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States

Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases

Emerging vaccine informatics

The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety

Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies

Rates of adverse events associated with male circumcision in U.S. medical settings, 2001 to 2010.

A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001

Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment

Childhood vaccinations and risk of asthma

The Brighton Collaboration: enhancing comparability of vaccine safety data

Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.

Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study.

Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems

Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment

Circumcision status and HIV infection among MSM: reanalysis of a Phase III HIV vaccine clinical trial

Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15–59 years of age

Standardized case definitions of adverse events following immunization (AEFI)

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).

Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination

Adverse event reports following vaccination for Lyme disease: December 1998-July 2000

Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines

Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program.

Myocarditis: the unexpected return of smallpox vaccine adverse events

Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997.

Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines

The Brighton Collaboration-enhancing vaccine safety

Template protocol for clinical trials investigating vaccines--focus on safety elements

Men Who Have Sex With Men in Kisumu, Kenya: Comfort in Accessing Health Services and Willingness to Participate in HIV Prevention Studies

Enhancing vaccine safety capacity globally: A lifecycle perspective

An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?

Hepatitis B vaccine and risk of multiple sclerosis

Wheezing lower respiratory disease and vaccination of full-term infants

Compliance With National Immunization Guidelines for Children Younger Than 2 Years, 1996-1999

Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial

Modeling the impact of RV144-like vaccines on HIV transmission

Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines